Sumitomo Pharma Co., Ltd. (TYO:4506)

Japan flag Japan · Delayed Price · Currency is JPY
2,441.00
+5.50 (0.23%)
At close: Dec 5, 2025
339.82%
Market Cap 969.78B
Revenue (ttm) 445.21B
Net Income (ttm) 154.72B
Shares Out 397.29M
EPS (ttm) 389.45
PE Ratio 6.27
Forward PE 11.35
Dividend n/a
Ex-Dividend Date n/a
Volume 6,466,400
Average Volume 11,655,270
Open 2,432.50
Previous Close 2,435.50
Day's Range 2,413.00 - 2,486.50
52-Week Range 500.00 - 2,765.00
Beta 0.53
RSI 54.81
Earnings Date Jan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, the company offers veterinary drugs, medical devices, etc. It h... [Read more]

Sector Healthcare
Founded 1897
Employees 3,832
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4506
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.